These findings have pioneered a new approach for the diagnosis and treatment of gastric cancer and demonstrated that miRNAs are likely to become a routine examination indicator for the development and prognosis of gastric cancer, similar to CA199, p53 or other tumor markers. The gene discussed is TP53; the disease is neoplasm.